🧬 Oncomine™ Myeloid Assay GX
🧪 Pathology is in our DNA
Innovative technology now enables simultaneous investigation of various myeloid malignancies in one streamlined approach. The Oncomine™ Myeloid Assay GX uses a highly automated workflow for fast, accurate, and cost-effective testing.
❓ What is it?
The Oncomine™ Myeloid Assay GX is a Next Generation Sequencing (NGS) solution that detects:
- 🧬 All clinically relevant myeloid genetic biomarkers
- 🧬 Mutations and fusions
- ✅ All in one comprehensive assay
🌟 Key Advantages
- 🔍 Comprehensive Testing
Detects mutations in 53 genes (DNA) and 30 fusions (RNA) - 🎯 High Accuracy
Outperforms FISH by detecting a broader range of gene rearrangements with greater sensitivity - ⏱️ Fast Turnaround
Genexus’ automated workflow delivers results quickly without compromising quality - 💸 Cost-Effective
One assay covers all clinically actionable genes and fusions
🧫 Sample Requirements
- 🧪 1 EDTA tube with ≥2ml bone marrow aspirate or peripheral blood
- 🚚 Must reach the lab within 72 hours for RNA extraction
⚠️ Limitations
- ❌ Does not detect copy number variations (e.g., trisomies/monosomies) or large structural deletions
📝 How to Request
- Use mnemonic: OMAGEN
- For DNA/RNA extraction on hold: OMAHOLD only
💡 Why Choose OMAGEN?
- ⏱️ Faster results
- 📊 Informative
- 🎯 Highly accurate
- 💰 Cost-effective
📧 For more info: ngs@ampath.co.za
🌐 Visit: ampath.co.za